12/12/2025
The Airavat Oct-Nov Bulletin is Here! 🎗️🫁
We are pleased to share the latest edition of the Airavat Cancer Care Monthly Charter. This edition bridges the gap between complex clinical advancements and vital public health education, reflecting on a busy season of awareness and resilience.
Pages 1-2: Editorial & Awareness Reflecting on Breast Cancer & Lung Cancer Awareness Months, we discuss how early detection is the strongest force in healthcare. We also celebrate the spirit of Diwali, dispelling the darkness of disease with the light of knowledge.
Page 3: Know Your Cancer (Re**um Cancer) A comprehensive clinical guide covering:
Symptoms: Changes in bowel habits, re**al bleeding, and tenesmus.
Diagnosis & Management: The role of biomarkers (CEA), MRI, and surgical options like Trans-Anal TME and Robotic-Assisted Surgery.
Page 4: 2025 St. Gallen Consensus Update
A critical resource for oncologists comparing 2023 vs. 2025 guidelines. Key updates include broadened genetic testing criteria and new standards for therapy de-escalation.
Page 5: Quality of Life in Breast Cancer Cancer care goes beyond surgery. We map out the physical, psychological, and social factors affecting patients, emphasizing the vital need for emotional support and coping strategies.
Page 6: Air Pollution (AQI) & Cancer "The air we breathe decides our future health." We explain the link between high AQI (PM2.5) and lung cancer risks, offering practical advice for protection.
Page 7: Clinical Success Stories
"Not Always...!!" – We challenge the bias against major surgery in the elderly with two inspiring cases: a 74-year-old and a 67-year-old successfully recovering from complex cytoreductive surgeries.
Pages 8-9: Media & Team Culture Highlights from our community engagement, including Dr. Manish Sadhwani on Fever FM, Dr. Samarth Dave on TV13 Gujarati, breast screening workshops, and our team’s Diwali celebrations.
Pages 10-11: Outreach & Locations Details on our OPD services across Amreli, Himmatnagar, Visnagar, Palanpur, and Surendranagar.